DCEMX
Price
$15.23
Change
-$0.02 (-0.13%)
Updated
Nov 19 closing price
Net Assets
128.79M
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

DCEMX vs VEIEX

Header iconDCEMX vs VEIEX Comparison
Open Charts DCEMX vs VEIEXBanner chart's image
Dunham Emerging Markets Stock C
Price$15.23
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets128.79M
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
DCEMX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
DCEMX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCEMX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. DCEMX (129M). VEIEX pays higher dividends than DCEMX: VEIEX (2.61) vs DCEMX (0.00). DCEMX was incepted earlier than VEIEX: DCEMX (21 years) vs VEIEX (32 years). DCEMX (2.26) is less costly to investors than VEIEX (0.29). DCEMX is a more actively managed with annual turnover of: 70.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than DCEMX: VEIEX (0) vs DCEMX (5000). DCEMX annual gain was more profitable for investors over the last year : 23.08 vs. VEIEX (20.18). VEIEX return over 5 years is better than : 23.38 vs. DCEMX (-5.11).
DCEMXVEIEXDCEMX / VEIEX
Total Expense Ratio2.260.29779%
Annual Report Gross Expense Ratio2.260.29779%
Fund Existence21 years32 years-
Gain YTD23.58222.205106%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRA2000N/A-
Net Assets129M141B0%
Annual Yield % from dividends0.002.61-
Returns for 1 year23.0820.18114%
Returns for 3 years39.6947.2384%
Returns for 5 years-5.1123.38-22%
Returns for 10 years42.0878.6154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics